RDH12 Human

Retinol Dehydrogenase 12 Human Recombinant
Cat. No.
BT14268
Source
E.coli.
Synonyms
Retinol dehydrogenase 12 (all-trans/9-cis/11-cis), LCA3, LCA13, SDR7C2, All-trans and 9-cis retinol dehydrogenase, short chain dehydrogenase/reductase family 7C, member 2, FLJ30273, EC 1.1.1.100.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

RDH12 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 303 amino acids (39-316) and having a molecular mass of 33.5kDa.
RDH12 is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
RDH12, a member of the short-chain Dehydrogenases / Reductases (SDR) family, is typically found in the brain, stomach, eye, skeletal muscle, and kidney. This NADPH-dependent retinal reductase primarily acts on 9-cis and all-trans-retinol. Additionally, RDH12 participates in metabolizing short-chain aldehydes but lacks steroid dehydrogenase activity.
Description
Recombinant human RDH12, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 303 amino acids (residues 39-316) with a molecular weight of 33.5 kDa. This protein is expressed with a 25 amino acid His-tag fused to the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The RDH12 solution (0.25 mg/ml) is supplied in a buffer containing 20 mM Tris-HCl (pH 8.0), 200 mM NaCl, 2 mM DTT, and 40% glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended periods, store frozen at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is determined to be greater than 90% by SDS-PAGE analysis.
Synonyms
Retinol dehydrogenase 12 (all-trans/9-cis/11-cis), LCA3, LCA13, SDR7C2, All-trans and 9-cis retinol dehydrogenase, short chain dehydrogenase/reductase family 7C, member 2, FLJ30273, EC 1.1.1.100.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMGKVVV ITGANTGIGK ETARELASRG ARVYIACRDV LKGESAASEI RVDTKNSQVL VRKLDLSDTK SIRAFAEGFL AEEKQLHILI NNAGVMMCPY SKTADGFETH LGVNHLGHFL LTYLLLERLK VSAPARVVNV SSVAHHIGKI PFHDLQSEKR YSRGFAYCHS KLANVLFTRE LAKRLQGTGV TTYAVHPGVV RSELVRHSSL LCLLWRLFSP FVKTAREGAQ TSLHCALAEG LEPLSGKYFS DCKRTWVSPR ARNNKTAERL WNVSCELLGI RWE

Product Science Overview

Structure and Function

RDH12 is a membrane-associated enzyme predominantly expressed in the retina, specifically at the base of photoreceptor inner segments . It is composed of 316 amino acids and has a molecular mass of approximately 35 kDa . The enzyme contains two highly conserved motifs among SDRs: the cofactor-binding site and catalytic residues .

The primary function of RDH12 is to catalyze the reduction of all-trans-retinal and its isomers (9-cis-, 11-cis-, and 13-cis-retinal) to their corresponding retinols in the presence of NADPH . This reaction is essential for the regeneration of 11-cis-retinal, a critical component of the visual cycle. RDH12 also metabolizes both all-trans- and cis-retinols, making it a dual-specificity enzyme .

Expression and Localization

RDH12 is predominantly expressed in the eye but is also found in other tissues such as the kidney, brain, skeletal muscle, and stomach . In situ hybridization studies in monkey and mouse retinas have shown that RDH12 is localized at the base of photoreceptor inner segments .

Clinical Significance

Mutations in the RDH12 gene are associated with Leber congenital amaurosis (LCA) and early-onset severe retinal dystrophy (EOSRD) . These conditions are characterized by severe vision loss at an early age. RDH12 mutations account for approximately 3.4% to 10.5% of LCA cases . The enzyme’s role in the visual cycle makes it a potential target for gene therapy aimed at treating inherited retinal diseases .

Research and Therapeutic Potential

Recombinant RDH12 has been expressed in insect cells as a membrane protein with enzymatic properties similar to those of the native enzyme . Studies have shown that RDH12 activity is inhibited by retinoic acids, recombinant cellular retinol-binding protein 1 (CRBP1), and cellular retinaldehyde-binding protein (CRALBP) . Understanding the enzyme’s function and regulation is crucial for developing therapeutic strategies for retinal diseases associated with RDH12 mutations.

In conclusion, Retinol Dehydrogenase 12 is a vital enzyme in the visual cycle and retinoid metabolism. Its role in retinal health and disease makes it an important target for research and potential therapeutic interventions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.